Ultrasound clot-buster Ekos raises $10M in debt
Ekos, a Bothell, Wash., maker of ultrasound-enhanced drug-delivery systems, raised $10 million in debt capital from Hercules Technology Growth Capital. The financing will support the sales and marketing of drug-delivery catheters that feature an ultrasound system designed to help drugs break up blood clots more quickly. Ekos launched its catheters in early 2006.
Ekos most recently raised $26 million in a third financing round led by Ascension Health Ventures, joined by new investors Oakwood Medical Investors and Trellis Health Ventures and previous investors CID Equity Capital, EGS Private Healthcare Investors, MedVenture Associates, Mitsui & Co. Venture Partners, Morgan Stanley Venture Partners and NGN Capital.
The company’s release is here.
Next Story: Neuromodulator Innovative Metabolics picks up $5.5M
Previous Story: Amgen buys kidney-disease treatment company, Ilypsa, for $420M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.